Skip to content
healthcare.dev

Talzenna

NDC 0069-1195, talazoparib, capsule, from Pfizer Laboratories Div Pfizer Inc.

Product NDC
0069-1195
Status
Listed
Labeler
Pfizer Laboratories Div Pfizer Inc
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA211651
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0069-1195 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TALAZOPARIB TOSYLATE1 mg/1

Pharmacologic classes

Poly(ADP-Ribose) Polymerase Inhibitor [EPC]; Poly(ADP-Ribose) Polymerase Inhibitors [MoA]

Package NDCNDC-11Package
0069-1195-30000691195301 BOTTLE in 1 CARTON (0069-1195-30) / 30 CAPSULE in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f2423edd-6d24-495c-aec1-c2f457f08d9a

Use it

Look up 0069-1195 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0069-1195 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0069-1195. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.